Russell Investments Group’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
LFCM
Russell Investments Group's LAB Position: Q3 2026 in Review
Russell Investments Group increased its Standard BioTools (LAB) stake by 95,349% in Q3 2026, buying an estimated $132K and bringing the position to 171,809 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #3397.
Russell Investments Group first reported a position in LAB in Q4 2016 and has held it in 26 quarters since. The position peaked at $74.2M in Q1 2019. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- Russell Investments Group held 171,809 shares of Standard BioTools worth $127K as of Q3 2026.
- Russell Investments Group bought 171,629 Standard BioTools shares in Q3 2026, an estimated $132K.
- Standard BioTools made up ﹤0.01% of Russell Investments Group's portfolio in Q3 2026, its #3397 holding.
- Russell Investments Group first reported a position in Standard BioTools in Q4 2016 and has held it in 26 quarters since.
- Russell Investments Group's Standard BioTools position peaked at $74.2M in Q1 2019.
- 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on Russell Investments Group's 13F filing for Q3 2026, filed 6 Nov 2026.